These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20444934)

  • 21. Post-operative diagnosis and therapy of thyroid carcinoma by nuclear medicine.
    Hundeshagen H
    Eur J Nucl Med; 1983; 8(12):541-5. PubMed ID: 6667704
    [No Abstract]   [Full Text] [Related]  

  • 22. Stunning with 131I diagnostic whole-body imaging of patients with thyroid cancer.
    Gerard SK; Dam HQ
    Radiology; 2005 Mar; 234(3):972-3; author reply 973-4. PubMed ID: 15734947
    [No Abstract]   [Full Text] [Related]  

  • 23. Correspondence between ultrasonography and histological features in a single thyroid nodule with coexisting follicular adenoma and papillary carcinoma.
    Deiana L; Lai ML; Carta G; Mariotti S
    Thyroid; 2008 Jul; 18(7):813-4. PubMed ID: 18631017
    [No Abstract]   [Full Text] [Related]  

  • 24. Current perspectives on papillary carcinoma of the thyroid gland.
    Chiu MK; Sherry RM; Wei JP
    J Med Assoc Ga; 1992 Aug; 81(8):442-4. PubMed ID: 1512532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic strategy of papillary microcarcinoma of the thyroid gland: a nuclear medicine perspective.
    Riemann B; Schober O
    Minerva Endocrinol; 2009 Mar; 34(1):81-7. PubMed ID: 19209130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The coexistence of anaplastic and papillary carcinomas of the thyroid: a case presentation and literature review.
    Fortson JK; Durden FL; Patel V; Darkeh A
    Am Surg; 2004 Dec; 70(12):1116-9. PubMed ID: 15663057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guidelines for the use of radio-iodine, thyroid hormone, and treatment of metastatic disease in patients with differentiated thyroid cancer.
    Paloyan E; Walker RP; Lawrence AM
    Surg Oncol Clin N Am; 1998 Oct; 7(4):665-80. PubMed ID: 9735128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radioiodine therapy for differentiated thyroid carcinoma.
    Connor CS; Thomas JH; Robinson RG; Preston DF; Hermreck AS
    Am J Surg; 1988 Dec; 156(6):519-21. PubMed ID: 3202264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Papillary thyroid cancer: a pediatric perspective.
    Flannery TK; Kirkland JL; Copeland KC; Bertuch AA; Karaviti LP; Brandt ML
    Pediatrics; 1996 Sep; 98(3 Pt 1):464-6. PubMed ID: 8784379
    [No Abstract]   [Full Text] [Related]  

  • 30. Artifactual I-131 activity in the hairs after thyroid remnant ablation.
    Bhargava P; Choi WS
    Thyroid; 2006 Nov; 16(11):1187-9. PubMed ID: 17123350
    [No Abstract]   [Full Text] [Related]  

  • 31. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Clear Cell Variant of Papillary Thyroid Microcarcinoma With Lung, Bone, and Soft Tissue Metastases.
    Yazici B; Ertan Y; Oral A; Akgün A
    Clin Nucl Med; 2015 Nov; 40(11):885-7. PubMed ID: 26018685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thyroid carcinoma metastatic to pituitary.
    Sziklas JJ; Mathews J; Spencer RP; Rosenberg RJ; Ergin MT; Bower BF
    J Nucl Med; 1985 Sep; 26(9):1097. PubMed ID: 4032051
    [No Abstract]   [Full Text] [Related]  

  • 34. Retention of iodine-131 in respiratory tract in a patient with papillary thyroid carcinoma after radionuclide therapy: a rare false-positive finding.
    Kienast O; Hofmann M; Ozer S; Dobrozemsky G; Dudczak R; Kurtaran A
    Thyroid; 2003 May; 13(5):509-10. PubMed ID: 12855020
    [No Abstract]   [Full Text] [Related]  

  • 35. Papillary microcarcinoma of the thyroid.
    Shaha AR; Tuttle RM; Shah JP
    J Surg Oncol; 2007 Jun; 95(7):532-3. PubMed ID: 17192917
    [No Abstract]   [Full Text] [Related]  

  • 36. Diagnosis, treatment, prognostic factors and long-term outcome in papillary thyroid carcinoma.
    Pelizzo MR; Merante Boschin I; Toniato A; Pagetta C; Casal Ide E; Mian C; Rubello D
    Minerva Endocrinol; 2008 Dec; 33(4):359-79. PubMed ID: 18923371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of differentiated carcinoma of the thyroid gland].
    Mimura T; Ito K
    Nihon Naika Gakkai Zasshi; 1997 Jul; 86(7):1184-9. PubMed ID: 9379097
    [No Abstract]   [Full Text] [Related]  

  • 38. [Iodine scintigraphy of differentiated thyroid carcinoma].
    Nakata K; Tsukamoto E; Ito K; Kato C; Furudate M
    Rinsho Hoshasen; 1988 May; 33(5):589-90. PubMed ID: 3047462
    [No Abstract]   [Full Text] [Related]  

  • 39. Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma.
    Min JJ; Chung JK; Lee YJ; Jeong JM; Lee DS; Jang JJ; Lee MC; Cho BY
    Eur J Nucl Med; 2001 May; 28(5):639-45. PubMed ID: 11383871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 201ti scintigraphy in postoperative detection of thyroid cancer: a comparative study with 131i.
    Tonami N; Hisada K
    Radiology; 1980 Aug; 136(2):461-4. PubMed ID: 7403524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.